• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    9.15 Down 0.16(1.72%) Feb 27, 4:00PM EST
    |After Hours : 9.10 Down 0.05 (0.55%) Feb 27, 7:58PM EST
    Add to Portfolio
    Prev Close:9.31
    Open:8.65
    Bid:7.50 x 400
    Ask:N/A
    1y Target Est:10.38
    Beta:0.73
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:8.51 - 9.25
    52wk Range:3.34 - 9.83
    Volume:5,261,671
    Avg Vol (3m):5,025,860
    Market Cap:2.18B
    P/E (ttm):N/A
    EPS (ttm):-0.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 1.72%2.18B
    MRKDown 0.71%166.89B
    NVSDown 0.58%245.62B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):72.40
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.40
    Quarterly EPS Est (Mar-15) :-0.10
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback